Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2004 by Favrille.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Favrille
ClinicalTrials.gov Identifier:
NCT00041730
First received: July 15, 2002
Last updated: September 29, 2009
Last verified: October 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given